Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: Wuxi apptec - The Untold Story

GLP-1 Weight-Loss Pills Made From Peptides May Need 10 to 100 Times the Active Ingredient of a Shot, Testing Drug Manufacturing

Oral GLP-1 drugs can require 10 to 100 times more peptide than injections because of poor absorption, increasing manufacturing, purification and supply demands for weight-loss treatments.

Medical Daily · Oct 29

BYD and Alibaba among big names aiding China’s military, Pentagon says

Updated Pentagon list includes swathe of China’s top technology firms in move that could inflame tensions between the countries

The Guardian - UK · Jun 9

US says BYD, Baidu and Alibaba and other tech giants are aiding China's military

The U.S. has updated its list of Chinese companies aiding Beijing's military, adding tech giants like Alibaba and Baidu, alongside chipmakers CXMT and YMTC. This move, superseding a 2025 list, could heighten U.S.-China tensions and impact firms through future contracting restrictions.

The Economic Times · Jun 9

From analysis to the latest developments in health,
read the most diverse news in one place.

US says BYD, Baidu and Alibaba are aiding China's military

America has released a new list of Chinese companies it believes support Beijing's military. Major firms like Alibaba, Baidu, and BYD are included. Other companies like WuXi AppTec and RoboSense Technology are also on the list. While not imposing immediate sanctions, the Pentagon will stop contracting with these firms in…

The Economic Times · Jun 8

Peter Mandelson’s lobbying firm hired by company linked to Chinese military

Global Counsel signed $3m contract with WuXi AppTec in Europe months after it was named in US national security drive

The Guardian - UK · Nov 27, 2025

Congress targets Chinese influence in health tech. It could come with tradeoffs

A San Jose-based biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China

The Independent UK · Sep 13, 2024

Stock Index Futures Muted Ahead of U.S. Presidential Debate, Inflation Data Awaited

September S&P 500 E-Mini futures (ESU24) are up +0.03%, and September Nasdaq 100 E-Mini futures (NQU24) are down -0.04% this morning as investors looked ahead to the U.S. presidential debate between Donald Trump and Kamala Harris, while also awaiting Wednesday’s release of a key U.S. inflation report.

Barchart · Sep 10, 2024

Read news from The Economist, FT, and more,
with one subscription

US House Passes Bill To Restrict Business With China's WuXi AppTec, BGI

The Biosecure Act would prohibit the U.S. from entering into contracts with the targeted firms, along with those who support them.

International Business Times · Sep 10, 2024

Stock Index Futures Inch Lower Ahead of U.S. Presidential Debate, Inflation Data Awaited

September S&P 500 E-Mini futures (ESU24) are down -0.07%, and September Nasdaq 100 E-Mini futures (NQU24) are down -0.27% this morning as investors looked ahead to the U.S. presidential debate between Donald Trump and Kamala Harris, while also awaiting Wednesday’s release of a key U.S. inflation report.

Barchart · Sep 10, 2024

US Bill Revised To Restrict Wuxi Apptec, Chinese Biotechs

US bill revised to address concerns over Chinese biotech firms collaborating with US institutions.

Wuxi Apptec Shared US Client Data With Beijing

US officials express concerns over WuXi AppTec sharing data with China, highlighting risks in cross-border collaborations.

Biotech Association To Split With China's Wuxi Apptec

US biotech trade association ends ties with WuXi AppTec over IP theft concerns, highlighting challenges in cross-border collaborations.

US Senate Bill Targets China's BGI And Wuxi Apptec

US Senate committee discusses bill targeting Chinese genetic companies for data privacy concerns.

US Lawmakers Demand Sanctions on China's WuXi AppTec Biotech Firm

US lawmakers are urging for sanctions on WuXi AppTec, a Chinese biotech firm. Learn more about the concerns and potential consequences.

US Bill Poses Risk to Wuxi AppTec and Western Drugmakers

Learn about the potential risks facing Wuxi AppTec and its Western drugmaker partners due to a new US bill, impacting their business operations. Stay informed!

Benzinga · Oct 24, 2022

What Pandemic? Joinn Lab Posts Bumper Profit Despite Covid Disruptions

Key Takeaways: Joinn Lab’s net profit in the first three quarters of this year surpassed the figure for all 2021 as the company rapidly expanded its capacity The company is strongly positioned due to high barriers to entry, and a broad presence in its industry chain through its acquisition of…

Benzinga · Jun 7, 2022

CStone Pharma Replaces Chairman Amid Huge Losses, Irregular Investment

Key Takeaways: CStone brought four products to market last year, and its losses have surged due to growing R&D and sales spending Appointment of chairman with close ties to WuXi AppTec reveals a power struggle between shareholders and management By Molly Wen

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.